Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,935.00
Bid: 1,750.00
Ask: 2,222.00
Change: 0.00 (0.00%)
Spread: 472.00 (26.971%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,935.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Resource Stocks Lead Gainers As Oil Recovers

Fri, 08th Apr 2016 07:37

LONDON (Alliance News) - Shares in London were higher Friday morning, with resource stocks leading the gainers as the oil prices take back some of their Thursday losses.

The FTSE 100 was up 0.8%, or 50.59 points, at 6,187.48. In Europe, the CAC 40 in Paris and the DAX 30 in Frankfurt were up 0.6% and 0.5%, respectively.

"Oil prices continue to get excited by the April 17 Doha meeting despite a chance of a production freeze deal looking slim to say the least with Iran saying 'No' and Saudi Arabia saying 'Only with Iran'. Desire is there, but as in break-up speak 'it's complicated'," said Accendo Markets head of research Mike van Dulken.

Brent oil was at USD40.11 a barrel shortly after the London equities open, higher than the USD38.93 a barrel at the close on Thursday.

Investors will keep a close eye later Friday on the US Baker Hughes oil rig count, scheduled for after the London equities close at 1800 BST.

Resource stocks were among the best performers in the FTSE 100, with Anglo American up 2.7%, Glencore up 2.4%, Rio Tinto up 2.3% and BHP Billiton up 2.2%. Oil company BP was up 1.3%, while Royal Dutch Shell's 'A' shares were up 1.1%.

Also among risers was Vodafone Group, after Deutsche Bank added the telecommunications company to its Short Term Buy List, according to traders.

Banks were also brightly green, with Standard Chartered up 2.1%, Royal Bank of Scotland Group up 1.6% and Lloyds Banking Group up 1.2%.

European banking stocks were hit Thursday after the ECB minutes "appeared to leave the door open to further negative interest rates, despite fears from some members about the adverse impacts on bank profitability," said CMC Markets analyst Jasper Lawler.

In its meeting on March 10, the ECB cut the main refinancing rate, which the central bank uses to boost liquidity, by five basis points to a record low 0.0%. The already-negative deposit rate was cut by 10 basis points to -0.40%, while there was a surprise five-basis-point cut to its marginal lending facility rate to 0.25%.

In the accounts, the ECB policymakers said they decided that a limited cut was appropriate as prospect of further cut cannot be ruled out if the inflation outlook deteriorates. Governing Council members broadly supported a further cut in the deposit facility rate and stressed the importance of communication and the link to the formulation of forward guidance.

The euro was at USD1.1354 after the open Friday. The single currency hit a high of USD1.1453 on Thursday but retreated following the release of the ECB accounts, standing at USD1.1373 at the London equities close.

Information services company Experian was the worst blue-chip performer early Friday, down 1.0%, after being downgraded to Reduce from Buy by HSBC. Meanwhile, insurer Schroders was cut to Neutral from Outperform by Exane BNP, sending its shares down 0.2%.

The FTSE 250 was up 0.4% at 16,781.27, while the AIM All-Share was up 0.1% at 717.83.

Hikma Pharmaceuticals and Vectura Group said the new drug application for their fluticasone propionate and salmeterol inhalation powder has been accepted for filing by the Food & Drug Administration in the US.

The two pharmaceutical companies are working together on the inhalation powder, which is a generic version of GlaxoSmithKline's Advair Diskus, which is used to treat asthma and to maintain treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

Shares in Hikma were up 1.0%, while Vectura Group was the best mid-cap performer, up 5.0%. In the FTSE 100, GlaxoSmithKline shares were down 0.1%.

At the other end of the FTSE 250, DFS Furniture was down 5.3% at 303.20 pence. Private equity firm Advent International said it agreed to sell a 14.1% stake in the sofa retailer for GBP90.0 million. Advent agreed to sell 30.0 million shares at 300.00 pence per share to institutional investors, leaving the private equity firm with a 24.1% stake in DFS, held through 51.4 million shares. Shares in DFS closed at 320.90p on Thursday.

UK manufacturing and industrial production data and trade balance are due at 0930 BST, while UK's NIESR gross domestic product estimate is due at 1500 BST.

"The CBI Industrial Trends survey and the manufacturing Purchasing Manager's Index output index both send the signal of some fall in manufacturing output in February," said analysts at French bank Societe Generale. "Accordingly, we predict that manufacturing production fell by 0.3% month-on-month in February after a rise by 0.7% month-on-month in January. Meanwhile, the trade deficit should stay within its narrow range, widening slightly from GBP3459 million to GBP3700 million in February".

In Asia on Friday, the Japanese Nikkei 225 index closed up 0.5%. In China, the Shanghai Composite ended down 0.8%, while the Hang Seng index in Hong Kong is down 0.2%.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more
20 Apr 2022 09:16

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.